A critical advance in cancer study is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This crucial malignant inhibitor protein is frequently inactivated in many kinds of malignancies, causing https://letsbookmarkit.com/story21921085/nanobodies-restore-p53-the-potential-pathway-for-malignant-therapy